Clinical Trials Browser

INDUSTRY × rocakinogene sifuplasmid × Genitourinary × Clear all

NCT03502785 2025-07-10

INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma

Phase 1/2 Completed

Carcinoma, Transitional Cell

NCT02514213 2017-12-26

Trial to Evaluate Safety and Immunogenicity of INO-5150 Alone or With INO-9012 in Men With Prostate Cancer

Phase 1 Completed

Prostatic Neoplasms